In a 2021 study by Tomohito Ishikawa et al., it was hypothesized that mtDNA could activate TLR9, thereby stimulating the accumulation of inflammatory cells and IL-6 production in the lungs of rats, leading to the progression of pulmonary arterial hypertension. The gene discussed is TLR9; the disease is pulmonary arterial hypertension.